Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
American Heart Association program leads to substantial improvements in stroke care
Cardiologist Gregg Fonarow, MD, reviewed decades of data and discussed the long-term impact of the AHA's Get With The Guidelines-Stroke program.
Bringing state-of-the-art healthcare to Florida heart patients
Naples Comprehensive Health is building up what it hopes will be a nationally recognized cardiology program. Robert Cubeddu, MD, and Dee Dee Wang, MD, spoke with Cardiovascular Business about the journey so far.
Society of Interventional Radiology seeks to bolster research funding for the specialty
During their annual meeting being held this week in Nashville, the society announced the launch of the SIR Foundation Endowment.

New PET method spots early signs of inflammatory bowel disease

The novel method could potentially guide decisions on when patients should start treatment.

Researchers have developed artificial blood vessels that could be as strong and durable as the real things, publishing their work in Advanced Materials Technologies.[1] The group hopes its work could go on to make a significant impact in care for heart bypass patients.

Artificial blood vessels could limit risks during heart bypass procedures

Even grafts that represent the current gold standard for bypass surgeries are associated with high failure rates, researchers noted. They think these 3D-printed blood vessels could provide considerable value.

Surgeons in Houston have performed the world’s first successful human implant of BiVACOR’s Total Artificial Heart (TAH) technology. The procedure was completed July 9, 2024, at The Texas Heart Institute at Baylor St. Luke’s Medical Center. It was part of an early feasibility study (EFS) first approved by the U.S. Food and Drug Administration (FDA) back in December 2023.

Texas surgeons first in world to perform ‘groundbreaking’ total artificial heart procedure

The BiVACOR technology was designed to serve as a bridge to heart transplant in patients with end-stage heart failure. Based on rotary blood pump technology, it is made of titanium and approximately the size of an adult’s fist.

Edwards Lifesciences Sapien 3 transcatheter heart valve used for Mitral Valve-in-Valve

Transcatheter mitral valve-in-valve replacement benefits intermediate-risk patients

New one-year data suggests transseptal MViV with a Sapien 3 heart valve is a "favorable and safe procedure." Researchers plan to follow patients for a total of 10 years.

Humana to open clinics at 23 empty Walmart Health locations

The clinics will open in 2025 with a new focus on providing primary care to seniors under the CareWell and Conviva brands.

Northwell Health launches film studio backed by Creative Artists Agency

The newly founded Northwell Studios will work on documentary and scripted projects that creatively “humanize” the healthcare experience for patients and clinicians.

Pharmacists help lower stroke risk in patients with undiagnosed, undertreated AFib

Researchers described pharmacies as an “attractive setting for community-based AFib screening."

FibriCheck, a Belgium-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) for its artificial intelligence-powered digital platform that uses smartphone cameras to obtain heart rhythm measurements.

FDA clears heart rhythm AI that turns smartphones into medical devices

FibriCheck has been increasing its presence in the United States in anticipation of this approval, opening a new office and partnering with U.S. hospitals.

Clinical

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

American Heart Association program leads to substantial improvements in stroke care

Bringing state-of-the-art healthcare to Florida heart patients

Society of Interventional Radiology seeks to bolster research funding for the specialty